ACE — Ascelia Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK393.94m
- SEK360.74m
Sweden's Ascelia Pharma Q1 loss narrows
Brief: Ascelia Pharma Q1 EBIT SEK -17.2 Million
Brief: Ascelia Pharma Q4 EPS Loss Narrows To Sek 0.13
Sweden's Ascelia Pharma Q4 operating loss narrows to SEK 15.8 mln
Brief: Ascelia Pharma CFO, Deputy CEO Julie Waras Brogren To Leave
Brief: FDA Sets Review Date For Ascelia Pharma's Orviglance NDA For July 3
Brief: Ascelia Pharma Files New Patent Application For Orviglance
Brief: Ascelia Pharma Q3 EBIT SEK -15.3 Million
Brief: Ascelia Pharma Recruits Anton Hansson As CFO
Brief: Ascelia Pharma Completes Directed Share Issue
Brief: Ascelia Pharma Submits Orviglance New Drug Application To FDA
Brief: Ascelia Pharma Q2 Operating Loss At SEK 23 Mln
Brief: Ascelia Pharma Q2 EBIT SEK -23 Million
Brief: Ascelia Pharma Q1 EBIT SEK -20.3 Million
Brief: Ascelia Pharma Q4 Operating Result Loss Widens to Sek 21.9 Mln
Brief: Ascelia Pharma Q4 EBIT SEK -21.9 Million
Brief: Ascelia Pharma Granted Chinese Patent For Second-Generation Orviglance
Brief: Ascelia Pharma Q3 Oper Loss Narrows To SEK 17.8 Mln
Brief: Ascelia Pharma Resolves On Convertibles Issue Of SEK 7.5 Mln